Therapy News and Research

RSS

St. Jude Medical launches 3-D navigation system that reduces need for live fluoroscopy

St. Jude Medical, Inc., a global medical device company, today announced the launch of its MediGuide Technology, the first and only three-dimensional (3-D) navigation system intended for the evaluation of vascular and cardiac anatomy on a recorded fluoroscopic image instead of live fluoroscopy (a series of X-ray images).

8 Oct 2012

Hygieia granted CE mark for d-Nav Diabetes Insulin Guidance System

Hygieia, Inc. today announced that the company's d-Nav Diabetes Insulin Guidance System (DIGS) has been granted a CE mark.

8 Oct 2012

FCP reports launch of comprehensive pharmacy services company, AlixaRx

Fillmore Capital Partners, a private investment company, today announced the formal launch of AlixaRx, a company that has been in development over the past four years. AlixaRx will provide comprehensive pharmacy services to post-acute and numerous other healthcare settings.

8 Oct 2012

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) doubles the response rate and improves time-to-progression and survival in patients with advanced lung cancer, according to a Phase II clinical trial conducted by investigators at Rational Therapeutics and the MemorialCare Todd Cancer Institute and published in the October issue of Anticancer Research.

8 Oct 2012

Patient navigation services can reduce dangerous delays in identification of breast cancer

Today researchers from The George Washington University published a study showing that breast cancer patients can reduce potentially dangerous delays in the identification of breast cancer with the assistance of patient navigation services.

8 Oct 2012

Parametric response mapping could improve diagnosis and treatment of COPD

A new approach to lung scanning could improve the diagnosis and treatment of a lung disease that affects approximately 24 million Americans and is the country's third-highest cause of death.

8 Oct 2012

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.

8 Oct 2012

FDA clears Fenwal's new plasma products

Fenwal Inc., a global leader specializing in separation technologies for blood and cell collection and therapy, announced today it has received clearance from the U.S. Food and Drug Administration for two new indications for collection of plasma products on the Fenwal Alyx and Amicus systems.

8 Oct 2012

Translational Genomics Research Institute creates new center for rare childhood disorders

The Translational Genomics Research Institute (TGen) today announced the creation of a new center that could have life changing effects on the lives of potentially thousands of children and their families.

6 Oct 2012

NIH awards $2.1M grant to study possible ways to fight cancer

A professor with the University of Houston Cullen College of Engineering has won a $2.1 million grant to study the best ways to modify human immune cells to fight against cancer.

6 Oct 2012

Nelfinavir inhibits growth of HER2-positive tumors

The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.

6 Oct 2012

91 charged with $430 million Medicare billing fraud

The nationwide sweep involved arrests of doctors, nurses and other licensed medical professionals.

6 Oct 2012

Time is of the essence in depressed diabetes patients

Among patients with diabetes and comorbid depression, the time point at which they developed depression may have important implications for their clinical management, say researchers.

5 Oct 2012

Lighting the way to vascular lesion resolution

Treatment with a new-generation optimized pulsed light device significantly decreases the size and coloration of port wine stains and other vascular cutaneous lesions, show research findings.

5 Oct 2012

Embolic agent useful in pediatric neurovascular lesions

Researchers report a low permanent morbidity rate when using the liquid embolic agent Onyx to treat cranial and spinal vascular lesions in children.

5 Oct 2012

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).

5 Oct 2012

MannKind completes enrollment in AFREZZA Phase 3 clinical studies for type 1 and 2 diabetes

MannKind Corporation today announced that it has completed recruiting patients for two Phase 3 clinical studies of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's to-be-marketed next-generation inhaler.

5 Oct 2012

Home hemodialysis more accessible than ever

Most patients with chronic kidney disease who undergo hemodialysis put up with a grueling treatment regimen that involves going into a clinic several days a week and sitting through a three-to-four hour dialysis session at each visit. Home hemodialysis is more accessible than ever, though, with the advent of newer systems that are easier for patients to learn, use, and maintain, according to a review appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

5 Oct 2012

GW professor to develop blood test for early detection of breast cancer

Today, patients with precancerous lesions, or early-stage breast cancer are usually diagnosed after a mammography screening. This method of detection can lead to false-positives and overtreatment, since mammography cannot determine whether pre-cancerous cells will actually turn into breast cancer. This may all change after Sidney Fu, M.D., professor of medicine at the George Washington School of Medicine and Health Sciences (SMHS), completes his study of early breast cancer detection using novel small RNA (microRNA or miRNA) biomarkers.

5 Oct 2012

Article explores safety and efficacy of aerosol delivery of drugs in ICU patients

Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.

5 Oct 2012

Therapy News and Research

St. Jude Medical launches 3-D navigation system that reduces need for live fluoroscopy

Hygieia granted CE mark for d-Nav Diabetes Insulin Guidance System

FCP reports launch of comprehensive pharmacy services company, AlixaRx

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Patient navigation services can reduce dangerous delays in identification of breast cancer

Parametric response mapping could improve diagnosis and treatment of COPD

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

FDA clears Fenwal's new plasma products

Translational Genomics Research Institute creates new center for rare childhood disorders

NIH awards $2.1M grant to study possible ways to fight cancer

Nelfinavir inhibits growth of HER2-positive tumors

91 charged with $430 million Medicare billing fraud

Time is of the essence in depressed diabetes patients

Lighting the way to vascular lesion resolution

Embolic agent useful in pediatric neurovascular lesions

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

MannKind completes enrollment in AFREZZA Phase 3 clinical studies for type 1 and 2 diabetes

Home hemodialysis more accessible than ever

GW professor to develop blood test for early detection of breast cancer

Article explores safety and efficacy of aerosol delivery of drugs in ICU patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News